DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Dormandy JA, Charbonnel B, Eckland DJA. et al for the PROactive investigators.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective piogliAzone Clinical Trial In macroVascular Events): a randomized controlled trial.
Lancet 2005; 366: 1279-1289
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.